Localization of parathyroid adenomas using c-methionine positron emission tomography

Nuclear Medicine Communications

Volumn 26, Issue 2, 2005, Pages 133-136

  Beggs, Andrew D ^a   Hain, Sharon F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Hyperparathyroidism; Parathyroid gland; Positron emission tomography (PET)

Indexed keywords

METHIONINE C 11;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYPERPARATHYROIDISM; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PARATHYROID ADENOMA; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; METHIONINE; MIDDLE AGED; PARATHYROID NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 13944280319     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200502000-00009     Document Type: Article

References (19)

1. Heath H III. Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Mineral Res 1991; 6:S63-S70.
2. Wells SA. Surgical therapy of patients with primary hyperparathyroidism: long term benefits. J Bone Mineral Res 1991; 6:S135-S152.
3. Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism. Consensus Development Conference Statement. Ann Intern Med 1991; 114:593-597.
4. Editorial. Medical management of primary hyperparathyroidism. Lancet 1984; 2:727-728.
5. McCance DR, Kenny BO, Sloan JM, Russell CFJ, Hadden DR. Parathyroid carcinoma: a review. Endocrine Rev 1982; 3:218-226.
6. O'Doherty MJ, Kettle AG. Parathyroid imaging: preoperative localisation. Nucl Med Commun 2003; 24:125-131.
7. Erdman WA, Breslan NA, Weinreb JC, Weatherall P, Setiawan H, Harrell R, et al. Noninvasive localization of parathyroid adenomas: a comparison of X-ray computerized tomography, ultrasound, scintigraphy and MRI. Magn Reson Imaging 1989; 7:187-194.
8. Auffermann W, Gooding GAW, Okerlund MD, Clark OH, Thurhner S, Kevin KE, et al. Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques. Am J Roentgenol 1988; 150:1027-1033.
9. Peck WW, Higgins CR, Fisher MR, Ling M, Okerland MD, Clark OH. Hyperparathyroidism: comparison of MR imaging with radionuclide scanning. Radiology 1987; 163:415-420.
10. Levin KE, Gooding GAW, Okerland M, Higgins CB, Norman D, Newton TH, et al. Localizing studies in patients with persistent or recurrent hyperparathyroidism. Surgery 1987; 102:917-925.
11. Miller DL, Doppman JR, Shawker TH, Krudy AG, Norton JA, Vucich JJ, et al. Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods. Radiology 1987; 162:133-137.
12. m sestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989; 10:791-794.
13. Coakley AJ. Nuclear medicine and parathyroid surgery: a change in practice. Nucl Med Commun 2003; 24:111-113.
14. Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ, et al. Comparison of FDG-PET and sestamibi SPECT in primary hyperparathyroidism. J Nucl Med 1996; 37:1809-1815.
15. Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995; 22:556-558.
16. Sundin A, Johansson C, Hellman P, Bergstrom M, Ahlstrom H, Jacobson GB, et al. PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 1996; 37:1766-1770.
17. Cook GJR, Wong JCH, Smellie WJB, Young AE, Maisey MN, Fogelman I. [11C] Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism. Eur J Endocrinol 1998; 139:195-197.
18. Pons F, Torregrosa JV, Fuster D. Biological factors influencing parathyroid localisation. Nucl Med Commun 2003; 24:121-124.
19. Hain SF, Beggs AD. Uptake of C11-methionine in granulomatous disease. Clin Nucl Med 2004; 29:585-586.